On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

We are excited to work with Abbott to empower healthcare providers and people living with diabetes ... the FreeStyle Libre ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

One in 10 adults with a chronic health condition believe their illness has been a factor in them being dumped – a behaviour ...

The research was conducted by Abbott's FreeStyle Libre, creators of continuous glucose ... Neil Harris, divisional vice ...

Many of us with loved ones living with diabetes want to see them thrive. We often think of ways we can ease some of their ...

Abbott's FreeStyle Libre Report: The Power of Positive Motivation for Type 2 Diabetes Management explores the experiences of Canadians with type 2 diabetes and the factors influencing their care.

Increasing diabetes care awareness, wider insurance coverage and preference for devices that do not need finger pricks have benefited CGMs such as Abbott's popular FreeStyle Libre. The company's ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.